Biojo Sciences 2026Biojo Sciences Driving Clinical Excellence In Today’s Industry Headwinds
Bethesda, Maryland – May 14, 2026
Biojo Sciences announces at the recent Clinical Outsourcing Group (COG) 2026 conference held in Bethesda, on May 12th – 13th, Senior Vice President Brandon Jurado delivered a keynote address titled “Clinical Excellence Through Strategic Outsourcing: A Small Biotech Perspective.” Sharing the event stage with esteemed leaders from Takeda, Pfizer, AstraZeneca, and Johns Hopkins, Jurado addressed how emerging biotechs can effectively navigate today’s industry headwinds, particularly in the face of constrained funding environments and complex regulatory changes. The presentation highlighted that overcoming these hurdles requires a highly collaborative, forward-thinking roadmap, reminding small biotech attendees that drug therapeutic innovation is ultimately a shared endeavor.
To build resilience and achieve global competitiveness, Jurado detailed the critical importance of executing multi-national clinical trial operations and forging strategic collaborations with specialized partners. He further underscored how integrating AI-based strategies and advanced operational technologies can streamline development and maximize limited resources. By adopting these strategic partnerships and technology-driven approaches, smaller organizations can accelerate efficient clinical pathways, ultimately ensuring that crucial therapies reach the patients who need them most.
